Back to results
US 2026/0217773 A1Published application
Compositions and methods for treating and preventing headaches
AssigneeNeurocarrus Inc.
InventorsRylie McDONELL, Derek ALLEN, Paul BLUM
Life of this patent
Estimating the term…
Abstract
Compositions and methods for preventing or reducing the occurrence of headache disorders in a subject in need thereof comprising administering to the subject an effective amount of a pharmaceutical composition comprising a nontoxic engineered protein derived from a botulinum toxin complex. The headache disorder may be selected from episodic migraine headaches, tension-type headaches, cluster headaches, hemiplegic migraine headaches, or retinal migraine headaches.
Claims19
A composition comprising:
- a) a target cell binding unit;
- b) a pore-forming unit,
- c) a rigid synthetic linker linking the target cell binding unit and the pore-forming unit, and
- d) a payload unit comprising the agent, wherein said payload unit binds non-covalently to a pore formed by the pore-forming unit upon activation and oligomerization of the pore-forming unit, wherein the payload unit has at least 90% sequence identity to the amino acid sequence of SEQ ID NO:
- 2;
- wherein the pore-forming unit is a polypeptide derived from a first AB type of non-neurotoxic binary toxin, and wherein the target cell binding unit is a polypeptide derived from a second AB type of toxin, said second AB type being different from the first AB type, wherein the target cell binding unit binds to a neural cell,
- wherein the target cell binding unit and the pore-forming unit are covalently linked through the rigid synthetic linker to form a polypeptide.
4 more elements
Dependencies are inferred from the claim text.